Workflow
QDII调仓路径曝光，重仓港股者领涨
2 1 Shi Ji Jing Ji Bao Dao·2025-07-21 13:13

Core Viewpoint - QDII funds are adjusting their portfolios in the second quarter of 2025, with a notable increase in allocation to Hong Kong stocks and a reduction in U.S. stocks, reflecting a strategic shift towards balanced asset allocation and recognition of investment opportunities in the Hong Kong market [1][2][5]. Group 1: Portfolio Adjustments - QDII funds have shown two main directions in their portfolio adjustments: some pharmaceutical-themed QDII funds are increasing their holdings in Hong Kong stocks while reducing their U.S. stock positions [1][4]. - Specific funds, such as the E Fund Global Pharmaceutical Industry Mixed Fund, reported a significant increase in their Hong Kong stock holdings from 748 million RMB to 1.1 billion RMB, while reducing U.S. stock holdings from 182 million RMB to zero [4]. - The Morgan China Biopharmaceutical Mixed Fund also increased its Hong Kong stock allocation from 29.40% to 45.56%, while decreasing A-share holdings [4]. Group 2: Market Performance and Fund Returns - The performance of QDII funds heavily invested in Hong Kong stocks has been strong, with the top ten performing QDII funds in 2025 being stock or mixed funds, achieving returns ranging from 71.12% to 133.72% [9][10]. - In contrast, QDII funds with significant exposure to overseas markets have underperformed, with some reporting negative returns due to various market challenges [10]. Group 3: Future Outlook - Fund managers remain optimistic about long-term investment opportunities in Hong Kong's innovative pharmaceutical sector, emphasizing the potential for growth in companies with global competitiveness [11]. - The technology sector in Hong Kong is also viewed favorably, with expectations for continued investment in high-quality internet companies that are undervalued compared to their overseas counterparts [12]. - The emerging "outbound 3.0" model is anticipated to enhance the prospects for Chinese high-end manufacturing and innovative products entering overseas markets, which could yield substantial profits [13].